Changliang Peng
- Molecular Biology
- Cancer Research
- Oncology
- Pulmonary and Respiratory Medicine
- Pathology and Forensic Medicine
- Topics
- Sarcoma Diagnosis and Treatment (6 papers)Cancer-related molecular mechanisms research (5 papers)Cancer-related gene regulation (4 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Changliang Peng
25 papers receiving 477 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 297
- Cancer Research 123
- Oncology 103
- Pulmonary and Respiratory Medicine 93
- Pathology and Forensic Medicine 50
Countries citing papers authored by Changliang Peng
This map shows the geographic impact of Changliang Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changliang Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changliang Peng more than expected).
Fields of papers citing papers by Changliang Peng
This network shows the impact of papers produced by Changliang Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changliang Peng. The network helps show where Changliang Peng may publish in the future.
Co-authorship network of co-authors of Changliang Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Changliang Peng. A scholar is included among the top collaborators of Changliang Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changliang Peng. Changliang Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 9 | |
| 5 | 30 | |
| 6 | 7 | |
| 7 | 14 | |
| 8 | PDCD5 inhibits osteosarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with good prognosis. | 8 |
| 9 | 5 | |
| 10 | 47 | |
| 11 | 20 | |
| 12 | 38 | |
| 13 | 40 | |
| 14 | 14 | |
| 15 | 43 | |
| 16 | 37 | |
| 17 | 31 | |
| 18 | 47 | |
| 19 | 15 | |
| 20 | 15 |
About Changliang Peng
Changliang Peng is a scholar working on Cancer Research, Genetics and Orthopedics and Sports Medicine, having authored 27 papers that have together received 482 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Cancer Research (123 citations), Molecular Biology (297 citations) and Oncology (103 citations). Changliang Peng has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Dongjin Wu, Xiuwen Wang, Hui Zhao, Tingting Ren, Xinchang Lu, Yong Qiao, Xiaoying Wang, Ji Li, Yan Song and Xiaoli Liu. Their work appears in journals such as Nature Communications, Journal of Experimental Botany and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.